Visual Interpretation, Not SUV Ratios, is the Ideal Method to Interpret 18F-DOPA PET Scans to Aid in the Cure of Patients with Focal Congenital Hyperinsulinism

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Oct 27

PMID 33108363

Citations 3

Authors

Pradeep K Garg

Burton Putegnat

Lisa Truong

Courtney Reynolds

Irene Sanchez

Jonathan K Nedrelow

John Uffman

Stephen J Lokitz

Rachid Nazih

Sudha Garg

Paul S Thornton

Affiliations

Soon will be listed here.

Abstract

Introduction: Congenital hyperinsulinism is characterized by abnormal regulation of insulin secretion from the pancreas causing profound hypoketotic hypoglycemia and is the leading cause of persistent hypoglycemia in infants and children. The main objective of this study is to highlight the different mechanisms to interpret the 18F-DOPA PET scans and how this can influence outcomes.

Materials And Methods: After 18F-Fluoro-L-DOPA was injected intravenously into 50 subjects' arm at a dose of 2.96-5.92 MBq/kg, three to four single-bed position PET scans were acquired at 20, 30, 40 and 50-minute post injection. The radiologist interpreted the scans for focal and diffuse hyperinsulinism using a visual interpretation method, as well as determining the Standard Uptake Value ratios with varying cut-offs.

Results: Visual interpretation had the combination of the best sensitivity and positive prediction values.

Conclusions: In patients with focal disease, SUV ratios are not as accurate in identifying the focal lesion as visual inspection, and cases of focal disease may be missed by those relying on SUV ratios, thereby denying the patients a chance of cure. We recommend treating patients with diazoxide-resistant hyperinsulinism in centers with dedicated multidisciplinary team comprising of at least a pediatric endocrinologist with a special interest in hyperinsulinism, a radiologist experienced in interpretation of 18F-Fluoro-L-DOPA PET/CT scans, a histopathologist with experience in frozen section analysis of the pancreas and a pancreatic surgeon experienced in partial pancreatectomies in patients with hyperinsulinism.

Citing Articles

International Guidelines for the Diagnosis and Management of Hyperinsulinism.

De Leon D, Arnoux J, Banerjee I, Bergada I, Bhatti T, Conwell L Horm Res Paediatr. 2023; 97(3):279-298.

PMID: 37454648 PMC: 11124746. DOI: 10.1159/000531766.

PET/CT in congenital hyperinsulinism: transforming patient's lives by molecular hybrid imaging.

Pizzoferro M, Masselli G, Maiorana A, Casciani E, Sollaku S, Dionisi-Vici C Am J Nucl Med Mol Imaging. 2022; 12(2):44-53.

PMID: 35535120 PMC: 9077170.

Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children.

Mitrofanova L, Perminova A, Ryzhkova D, Sukhotskaya A, Bairov V, Nikitina I Front Endocrinol (Lausanne). 2021; 12:710947.

PMID: 34497584 PMC: 8419459. DOI: 10.3389/fendo.2021.710947.

References

Ribeiro M, Boddaert N, Bellanne-Chantelot C, Bourgeois S, Valayannopoulos V, Delzescaux T . The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging. 2007; 34(12):2120-8. DOI: 10.1007/s00259-007-0498-y. View

Wagner F, Ermert J, Coenen H . Three-step, "one-pot" radiosynthesis of 6-fluoro-3,4-dihydroxy-L-phenylalanine by isotopic exchange. J Nucl Med. 2009; 50(10):1724-9. DOI: 10.2967/jnumed.109.063297. View

Rahier J, Sempoux C, Fournet J, POGGI F, Brunelle F, Nihoul-Fekete C . Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist's role. Histopathology. 1998; 32(1):15-9. DOI: 10.1046/j.1365-2559.1998.00326.x. View

Thornton P, Truong L, Reynolds C, Hamby T, Nedrelow J . Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism. Horm Res Paediatr. 2019; 91(1):25-32. DOI: 10.1159/000497458. View

Huang Q, Bu S, Yu Y, Guo Z, Ghatnekar G, Bu M . Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase. Endocrinology. 2006; 148(1):81-91. DOI: 10.1210/en.2006-0738. View

Sweet I, Cook D, Lernmark A, Greenbaum C, Wallen A, Marcum E . Systematic screening of potential beta-cell imaging agents. Biochem Biophys Res Commun. 2004; 314(4):976-83. DOI: 10.1016/j.bbrc.2003.12.182. View

Cretolle C, Nihoul Fekete C, Jan D, Nassogne M, Saudubray J, Brunelle F . Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: A report of 45 cases from 1983 to 2000. J Pediatr Surg. 2002; 37(2):155-8. DOI: 10.1053/jpsu.2002.30241. View

Blomberg B, Moghbel M, Saboury B, Stanley C, Alavi A . The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol. 2012; 15(1):97-105. PMC: 3553406. DOI: 10.1007/s11307-012-0572-0. View

Laje P, States L, Zhuang H, Becker S, Palladino A, Stanley C . Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism. J Pediatr Surg. 2013; 48(2):388-93. PMC: 3597386. DOI: 10.1016/j.jpedsurg.2012.11.025. View

10.

Pierro A, Nah S . Surgical management of congenital hyperinsulinism of infancy. Semin Pediatr Surg. 2010; 20(1):50-3. DOI: 10.1053/j.sempedsurg.2010.10.009. View

11.

von Rohden L, Mohnike K, Mau H, Eberhard T, Mohnike W, Blankenstein O . Visualization of the focus in congenital hyperinsulinism by intraoperative sonography. Semin Pediatr Surg. 2010; 20(1):28-31. DOI: 10.1053/j.sempedsurg.2010.10.011. View

12.

Mohnike K, Blankenstein O, Minn H, Mohnike W, Fuchtner F, Otonkoski T . [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism. Horm Res. 2008; 70(2):65-72. DOI: 10.1159/000137655. View

13.

Barthlen W, Blankenstein O, Mau H, Koch M, Hohne C, Mohnike W . Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab. 2007; 93(3):869-75. DOI: 10.1210/jc.2007-2036. View

14.

Borelli M, Villar M, Orezzoli A, Gagliardino J . Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab. 1997; 23(2):161-3. View

15.

Fournet J, Sempoux C, Dionisi Vici C, Brunelle F, Touati G, Rahier J . Clinical features of 52 neonates with hyperinsulinism. N Engl J Med. 1999; 340(15):1169-75. DOI: 10.1056/NEJM199904153401505. View

16.

Kauhanen S, Seppanen M, Minn H, Gullichsen R, Salonen A, Alanen K . Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab. 2007; 92(4):1237-44. DOI: 10.1210/jc.2006-1479. View

17.

Jakoby B, Bercier Y, Conti M, Casey M, Bendriem B, Townsend D . Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol. 2011; 56(8):2375-89. DOI: 10.1088/0031-9155/56/8/004. View

18.

Otonkoski T, Nanto-Salonen K, Seppanen M, Veijola R, Huopio H, Hussain K . Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes. 2005; 55(1):13-8. View

19.

Cherian M, Abduljabbar M . Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): Long-term outcome following 95% pancreatectomy. J Pediatr Endocrinol Metab. 2006; 18(12):1441-8. DOI: 10.1515/jpem.2005.18.12.1441. View

20.

Glaser B, Hirsch H, Landau H . Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr. 1993; 123(4):644-50. DOI: 10.1016/s0022-3476(05)80970-9. View